These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Asymptomatic myocardial ischemia in the dynamics of anaprilin and korinfar treatment]. Volkov VI; Ermakovich II; Strona VI Lik Sprava; 1997; (5):114-7. PubMed ID: 9491715 [TBL] [Abstract][Full Text] [Related]
24. [Silent myocardial ischemia. Arguments in favor of treatment]. Lezaun R; Maraví C; Gervás H; Madariaga I; Basterra N; de los Arcos E Rev Esp Cardiol; 1996 Jan; 49(1):1-5. PubMed ID: 8685506 [No Abstract] [Full Text] [Related]
25. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Ruzyllo W; Tendera M; Ford I; Fox KM Drugs; 2007; 67(3):393-405. PubMed ID: 17335297 [TBL] [Abstract][Full Text] [Related]
26. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists]. Hanai Y; Mita M; Hishinuma S; Shoji M Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416 [TBL] [Abstract][Full Text] [Related]
27. Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group. Braun S; van der Wall EE; Emanuelsson H; Kobrin I J Am Coll Cardiol; 1996 Feb; 27(2):317-22. PubMed ID: 8557900 [TBL] [Abstract][Full Text] [Related]
28. Silent ischemia and beta-blockade. Egstrup K Circulation; 1991 Dec; 84(6 Suppl):VI84-92. PubMed ID: 1683614 [TBL] [Abstract][Full Text] [Related]
29. Treatment of silent ischemia in unstable angina: a randomized comparison of sustained-release verapamil versus metoprolol. Singh N; Mironov D; Goodman S; Morgan CD; Langer A Clin Cardiol; 1995 Nov; 18(11):653-8. PubMed ID: 8590535 [TBL] [Abstract][Full Text] [Related]
30. Theoretical considerations in the use of calcium entry blockers in silent myocardial ischemia. Crawford MH Circulation; 1989 Dec; 80(6 Suppl):IV74-7. PubMed ID: 2574641 [TBL] [Abstract][Full Text] [Related]
31. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. Gottlieb SO; Weisfeldt ML; Ouyang P; Mellits ED; Gerstenblith G N Engl J Med; 1986 May; 314(19):1214-9. PubMed ID: 2871485 [TBL] [Abstract][Full Text] [Related]
32. Silent myocardial ischemia: to treat or not to treat? Cohn PF Hosp Pract (Off Ed); 1994 Jun; 29(6):107-12; 115-6. PubMed ID: 7911474 [TBL] [Abstract][Full Text] [Related]
33. Silent myocardial ischemia. Rationale for management. Pepine CJ; Coy K; Lambert CR; Hill JA; Norvell N Postgrad Med; 1988 Feb; Spec No():76-82. PubMed ID: 2894663 [TBL] [Abstract][Full Text] [Related]
34. [Beta blockers in stable angina pectoris]. Fluri M; Meier B Praxis (Bern 1994); 1995 Mar; 84(10):288-95. PubMed ID: 7892549 [TBL] [Abstract][Full Text] [Related]
35. Antianginal drug therapy for silent myocardial ischemia. Frishman WH; Teicher M Med Clin North Am; 1988 Jan; 72(1):185-96. PubMed ID: 3276984 [TBL] [Abstract][Full Text] [Related]
36. Psychological risk factors may moderate pharmacological treatment effects among ischemic heart disease patients. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. Rutledge T; Linden W; Davies RF Psychosom Med; 1999; 61(6):834-41. PubMed ID: 10593636 [TBL] [Abstract][Full Text] [Related]